FGFR3 and plasma cell myeloma: Particularly noteworthy is the t(4;14) translocation of FGFR3 and MMSET (Multiple Myeloma Set domain), which occurs in approximately 15% of MM patients and is associated with poor prognosis and resistance to chemotherapeutic measures [48].